CD14 and breast carcinoma: In breast cancer patients, both MDSC subsets (m-MDSC, CD14+ HLA-DR−; and g-MDSC, CD14− CD11b+ CD15+ [137]) appear to be more abundant than in healthy individuals [64,71,78,145,149,150,151].